These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 7730696)

  • 1. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
    Shimizu K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
    Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
    Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of DNA ploidy in endometrial cancer.
    Ikeda M; Watanabe Y; Nanjoh T; Noda K
    Gynecol Oncol; 1993 Jul; 50(1):25-9. PubMed ID: 8349160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
    Takahashi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma.
    Goodman A; Bell DA; Rice LW
    Gynecol Oncol; 1993 Dec; 51(3):355-61. PubMed ID: 8112645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of deoxyribonucleic acid ploidy status on survival of patients with carcinoma of the endometrium.
    Dyas CH; Simmons TK; Ellis CN; Austin JM; Partridge EE; Kilgore LC; Reading C; Nelson K; Blakemore WS
    Surg Gynecol Obstet; 1992 Feb; 174(2):133-6. PubMed ID: 1734571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flow cytometric evaluation of DNA ploidy pattern in uterine cancer].
    Watanabe T; Izumi S; Yamaoka K; Tsutsui F; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2432-8. PubMed ID: 1447814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell cycle in patients with stage I endometrial carcinoma.
    Vecek N; Nola M; Marusić M; Babić D; Uzarević B; Sabioncello A; Petrovecki M; Ljubić-Racunica N; Marinović T
    Gynecol Oncol; 1994 Apr; 53(1):38-43. PubMed ID: 8175020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on DNA content and cell cycle phase analysis in endometrial carcinoma].
    Xue F; Jiao S; Zhao F
    Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):216-9. PubMed ID: 8758776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of DNA ploidy and ERB-B2 oncogene expression in the prognosis of endometrial carcinoma.
    Ferrara F; De Santis L; Mangili F; Sassi I; Luchini S; Mandelli C; Santambrogio G; Cantaboni A
    Pathol Res Pract; 1994 Nov; 190(11):1039-43. PubMed ID: 7746737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study.
    Friberg LG; Norén H; Delle U
    Gynecol Oncol; 1994 Apr; 53(1):64-9. PubMed ID: 8175025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
    Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
    Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric DNA-ploidy as a prognostic indicator in oral squamous cell carcinoma.
    Wang XL; Chen RM; Wang ZS; Chen WL; Zuo LF
    Chin Med J (Engl); 1990 Jul; 103(7):572-5. PubMed ID: 2119974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
    Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
    Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of flow cytometric DNA analysis in metastatic lymph node of colorectal cancer].
    Ando Y; Tsuchiya A; Katagata N; Kanazawa M; Watanabe F; Sato H; Kikuchi Y; Yoshida T; Abe R
    Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():41-6. PubMed ID: 8203929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytophotometric studies for evaluating the prognosis in endometrial cancer].
    Köhler U; Krug H; Taubert G
    Zentralbl Gynakol; 1991; 113(24):1371-9. PubMed ID: 1808964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flow cytometric DNA analysis of malignant potential in colorectal cancer].
    Ando Y; Tsuchiya A; Oki S; Sato H; Yoshida T; Kimijima I; Abe R
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():112-7. PubMed ID: 8678552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.